122 related articles for article (PubMed ID: 37326252)
1. T1dCteGui: A User-Friendly Clinical Trial Enrichment Tool to Optimize T1D Prevention Studies by Leveraging AI/ML Based Synthetic Patient Population.
Pauley M; Henscheid N; David SE; Karpen SR; Romero K; Podichetty JT;
Clin Pharmacol Ther; 2023 Sep; 114(3):704-711. PubMed ID: 37326252
[TBL] [Abstract][Full Text] [Related]
2. Leveraging Real-World Data for EMA Qualification of a Model-Based Biomarker Tool to Optimize Type-1 Diabetes Prevention Studies.
Podichetty JT; Lang P; O'Doherty IM; David SE; Muse RN; Karpen SR; Song LS; Romero K; Burton JK;
Clin Pharmacol Ther; 2022 May; 111(5):1133-1141. PubMed ID: 35276013
[TBL] [Abstract][Full Text] [Related]
3. Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies.
Karpen SR; Dunne JL; Frohnert BI; Marinac M; Richard C; David SE; O'Doherty IM;
Diabetologia; 2023 Mar; 66(3):415-424. PubMed ID: 35867129
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes.
Simmons KM; Sosenko JM; Warnock M; Geyer S; Ismail HM; Elding Larsson H; Steck AK
J Clin Endocrinol Metab; 2020 Nov; 105(11):e4094-101. PubMed ID: 32844178
[TBL] [Abstract][Full Text] [Related]
6. Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 Diabetes.
Baidal DA; Warnock M; Xu P; Geyer S; Marks JB; Moran A; Sosenko J; Evans-Molina C
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3273-e3280. PubMed ID: 35524749
[TBL] [Abstract][Full Text] [Related]
7. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance.
Redondo MJ; Sosenko J; Libman I; McVean JJF; Tosur M; Atkinson MA; Becker D; Geyer S
J Clin Endocrinol Metab; 2020 May; 105(5):1629-40. PubMed ID: 31867614
[TBL] [Abstract][Full Text] [Related]
8. High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes.
Jia X; He L; Miao D; Waugh K; Rasmussen CG; Dong F; Steck AK; Rewers M; Yu L
J Clin Endocrinol Metab; 2021 Nov; 106(12):3455-3463. PubMed ID: 34343303
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of glucose metabolism in preclinical type 1 diabetes.
Veijola R; Koskinen M; Helminen O; Hekkala A
Pediatr Diabetes; 2016 Jul; 17 Suppl 22():25-30. PubMed ID: 27411433
[TBL] [Abstract][Full Text] [Related]
10. Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results.
Winkler C; Haupt F; Heigermoser M; Zapardiel-Gonzalo J; Ohli J; Faure T; Kalideri E; Hommel A; Delivani P; Berner R; Kordonouri O; Roloff F; von dem Berge T; Lange K; Oltarzewski M; Glab R; Szypowska A; Snape MD; Vatish M; Todd JA; Larsson HE; Ramelius A; Kördel JÅ; Casteels K; Paulus J; Ziegler AG; Bonifacio E;
Pediatr Diabetes; 2019 Sep; 20(6):720-727. PubMed ID: 31192505
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants.
Sosenko JM; Mahon J; Rafkin L; Lachin JM; Krause-Steinrauf H; Krischer JP; Cuthbertson D; Palmer JP; Thompson C; Greenbaum CJ; Skyler JS;
Pediatr Diabetes; 2011 Mar; 12(2):85-90. PubMed ID: 20522170
[TBL] [Abstract][Full Text] [Related]
12. Exploring Minimally Invasive Approach to Define Stages of Type 1 Diabetes Remotely.
Kontola H; Alanko I; Koskenniemi JJ; Löyttyniemi E; Itoshima S; Knip M; Veijola R; Toppari J; Kero J
Diabetes Technol Ther; 2022 Sep; 24(9):655-665. PubMed ID: 35653748
[No Abstract] [Full Text] [Related]
13. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
[TBL] [Abstract][Full Text] [Related]
14. Lessons and gaps in the prediction and prevention of type 1 diabetes.
Mameli C; Triolo TM; Chiarelli F; Rewers M; Zuccotti G; Simmons KM
Pharmacol Res; 2023 Jul; 193():106792. PubMed ID: 37201589
[TBL] [Abstract][Full Text] [Related]
15. Clinical and HLA genotype analysis of immune checkpoint inhibitor-associated diabetes mellitus: a single-center case series from China.
Liu YC; Liu H; Zhao SL; Chen K; Jin P
Front Immunol; 2023; 14():1164120. PubMed ID: 37359544
[TBL] [Abstract][Full Text] [Related]
16. Negativation of type 1 diabetes-associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol.
Papadimitriou DT; Marakaki C; Fretzayas A; Nicolaidou P; Papadimitriou A
J Diabetes; 2013 Sep; 5(3):344-8. PubMed ID: 23302101
[TBL] [Abstract][Full Text] [Related]
17. Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)-study protocol for a phase 2, randomized, placebo controlled trial.
Waibel M; Thomas HE; Wentworth JM; Couper JJ; MacIsaac RJ; Cameron FJ; So M; Krishnamurthy B; Doyle MC; Kay TW
Trials; 2022 May; 23(1):433. PubMed ID: 35606820
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.
Skyler JS; Pugliese A
Diabetes Technol Ther; 2013 Jun; 15 Suppl 2(Suppl 2):S2-13-S2-20. PubMed ID: 23786294
[TBL] [Abstract][Full Text] [Related]
19. Islet Autoantibodies.
Lampasona V; Liberati D
Curr Diab Rep; 2016 Jun; 16(6):53. PubMed ID: 27112957
[TBL] [Abstract][Full Text] [Related]
20. Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFA.
Martinez MM; Salami F; Larsson HE; Toppari J; Lernmark Å; Kero J; Veijola R; Koskenniemi JJ; Tossavainen P; Lundgren M; Borg H; Katsarou A; Maziarz M; Törn C;
Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00198. PubMed ID: 33855205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
